Sugar element of keratan sulfate halts the progress of emphysema
Using a mouse model, scientists have identified a sugar molecule that reduced the inflammatory response and progress of emphysema, a common component of chronic obstructive pulmonary disease (COPD). This discovery could lead to the development of drugs based on glycans -- biological sugar molecules -- for the treatment of diseases such as COPD, which is the fourth leading cause of death worldwide.
Source: ScienceDaily Headlines - Category: Science Source Type: news